Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_assertion type Assertion NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_head.
- NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_provenance.
- NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_assertion evidence source_evidence_literature NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_provenance.
- NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_assertion SIO_000772 22334453 NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_provenance.
- NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_assertion wasDerivedFrom befree-20140225 NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_provenance.
- NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_assertion wasGeneratedBy ECO_0000203 NP427393.RAysE32mxkl7MuGwl3IDmjVytBPqBzXD9YIzeGWMQ55_Q130_provenance.